CTS Research Consortium was established to further CTS’s leadership in infectious disease research. This collaboration between Vitalant Research Institute, Carter BloodCare, OneBlood, ITxM, New York Blood Center and Bloodworks Northwest will provide a wealth of data for the development of future hypothesis-based research studies.
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...